Sunshine Lake Pharma Co., Ltd. (HKG:6887)
46.00
-0.42 (-0.90%)
At close: Oct 30, 2025
Sunshine Lake Pharma Market Cap
Sunshine Lake Pharma has a market cap or net worth of 26.41 billion as of October 31, 2025. Its market cap has increased by 232.74% in one year.
Market Cap
26.41B
Enterprise Value
27.29B
Revenue
3.96B
Ranking
n/a
PE Ratio
20.68
Stock Price
46.00
Market Cap Chart
Since December 29, 2015, Sunshine Lake Pharma's market cap has increased from 6.55B to 26.41B, an increase of 303.06%. That is a compound annual growth rate of 15.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 26.53B | 215.32% |
| Dec 31, 2024 | 8.41B | 0.74% |
| Dec 29, 2023 | 8.35B | 46.00% |
| Dec 30, 2022 | 5.72B | 6.56% |
| Dec 31, 2021 | 5.37B | -30.92% |
| Dec 31, 2020 | 7.77B | -60.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 263.63B |
| Hansoh Pharmaceutical Group Company | 207.05B |
| JD Health International | 194.33B |
| WuXi Biologics | 148.69B |
| Innovent Biologics | 138.28B |
| Sino Biopharmaceutical | 122.81B |
| Akeso | 102.15B |
| Sichuan Kelun-Biotech Biopharmaceutical | 98.31B |